# Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)

> **NCT00358644** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 55 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT00358644
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2008-02
- **Final completion:** 2008-12
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2013-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358644, "Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00358644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*